{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-000198","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2023-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.855501+00:00","generated_at":"2026-06-20T20:08:28.943300+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GT Biopharma raises $6.5M in registered direct offering of shares and warrants at $1.00 per unit","bullets":["Offering of 6.5M shares or pre-funded warrants plus 6.5M warrants to purchase common stock.","Gross proceeds of $6.5 million, before placement agent fees and expenses.","Warrants exercisable at $1.00 per share, beginning six months after issuance, for five years.","H.C. Wainwright & Co. acted as exclusive placement agent; cash fee of $390,000 paid.","Net proceeds to be used for general corporate purposes; closing expected January 4, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-000198","json":"https://secwatch.observer/filing/0001493152-23-000198.json","markdown":"https://secwatch.observer/filing/0001493152-23-000198.md","text":"https://secwatch.observer/filing/0001493152-23-000198.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/0001493152-23-000198-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:08:28.943300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}